Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

 

Curaleaf Holdings, Inc., its subsidiaries and managed entities are directly engaged in the manufacture, possession, use, sale or distribution of cannabis and/or hold licenses in the adult-use and/or medicinal cannabis marketplace in the States of Arizona, Connecticut, Florida, Maine, Maryland, Massachusetts, Nevada, New Jersey, New York and Oregon.

Investor Note: In addition to the 588,790,581 Subordinate Voting Shares that are listed and trading, there are 93,970,705 shares reserved specifically for issuance pursuant to the conversion rights attached to the Multiple Voting Shares that are issued and outstanding but not listed. The total number of issued shares assuming all Multiple Voting Shares are converted into the listed class would be 682,761,286.

Discover Wellness (formerly RMMI Corp.) is a Canadian company licensed, through its subsidiary, to cultivate, produce, process and sell cannabis in various forms. The Company’s vision is to enhance shareholder value by establishing cost leadership in hemp processing and CBD extraction coupled with a global distribution strategy.

Eden Empire is in the business of investments and operations in the cannabis sector and engaging in retail cannabis sales in Canada and the United States.

Entheon is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (“DMT Products”) for the purposes of treating addiction and substance use disorders. Subject to obtaining all requisite regulatory approvals and permits, Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics and licensed psychiatrists in the United States, certain countries in the European Union and throughout Canada.    

Eviana Health Corporation’s aim is to deliver customized consumer skin care products using natural hemp strains of cannabis sativa for cosmeceutical and nutraceutical merchandise and cannabinoid-based topical creams and products.

EXMceuticals (“EXM”) is a bio-science company that strongly believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with the ambition to become one of the world's suppliers of highest-grade cannabis ingredients. EXM is currently creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. EXM has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients to the pharmaceutical, medicinal and wellness industry.

Field Trip is a global leader in the development and delivery of psychedelic therapies. With Field Trip Discovery, the Company’s research division, leading the development of the next generation of psychedelic molecules and conducting advanced research on plant-based psychedelics, Field Trip Health clinics for psychedelic therapies operating and opening within North America and Field Trip Digital, the Company’s technology division, building the digital and technological tools to support psychedelic experiences and consciousness expansion, we help people, from those in treatment to those seeking accelerated personal growth, with a simple, evidence-based way to heal and heighten engagement with the world.

Field Trip is a global leader in the development and delivery of psychedelic therapies. With Field Trip Discovery, the Company’s research division, leading the development of the next generation of psychedelic molecules and conducting advanced research on plant-based psychedelics, Field Trip Health clinics for psychedelic therapies operating and opening within North America and Field Trip Digital, the Company’s technology division, building the digital and technological tools to support psychedelic experiences and consciousness expansion, we help people, from those in treatment to those seeking accelerated personal growth, with a simple, evidence-based way to heal and heighten engagement with the world.

FinCanna Capital Corp. is a royalty company for the licensed medical cannabis industry which invests in sizable and scalable best-in-class businesses. The Issuer’s business objective is to provide capital solutions to companies in the medical cannabis industry with large scale potential, a highly skilled and experienced operator, which plan to produce high value, high demand licensed medical products or related products and services.  

Contact The Team

How can we help you?

Contact the CSE team to find out more.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2021-01-26_Jamaica_Stock_Exchange_16th_Annual_Conference_Website.png

Jamaica Stock Exchange 16th Annual Regional Investments and Capital Markets Conference

Tuesday, January 26, 2021 - 6:30pm to Thursday, January 28, 2021 - 4:00pm

Advertisement

Publicité